pyrrolidine-2,4-dicarboxylic acid has been researched along with Ataxia in 1 studies
pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z | 1 |
| Hulsizer, S | 1 |
| Cui, Y | 1 |
| Pretto, DL | 1 |
| Kim, KH | 1 |
| Hagerman, PJ | 1 |
| Tassone, F | 1 |
| Pessah, IN | 1 |
1 other study available for pyrrolidine-2,4-dicarboxylic acid and Ataxia
| Article | Year |
|---|---|
Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion.
Topics: Animals; Astrocytes; Ataxia; Biological Transport; Calcium Signaling; Cells, Cultured; Cerebral Cort | 2013 |